http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101648923-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87a3b5dd31ed259c07d057e147db6290 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 |
| filingDate | 2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08f801c99153be8de0f1735de6f61bc6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24da962a057dc0a9283cebda3a7df114 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b188e243eee4474d40798be38ccb24a |
| publicationDate | 2012-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101648923-B |
| titleOfInvention | Hydroxamic acid compound used as histone deacetylase inhibitor and application thereof |
| abstract | The invention discloses a compound in the formula (I) or pharmaceutically acceptable salt thereof. Ar is aryl or heterocyclic group and is substituted by optional one or more of the following groups: C1-8 alkyl, C1-8 alkoxy, halogen, nitryl, C1-8 aminoalkyl, C1-8 alkyl amino group, C1-8 thio-alkyl, C1-8 halogenated alkyl, C1-8 halogenated alkoxy, C1-8 ester group, phenyl or heterocyclic group. R1is hydrogen or C1-8 alkyl. The drugs prepared by the compound can be used for treating solid tumors or leukemia correlating with cell differentiation or proliferation. |
| priorityDate | 2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.